Ticker League

Estimates for Xylem (XYL)

Analyst consensus revenue & EPS estimates for Xylem (XYL) — Q2 2026. Compare the numbers and make your own prediction.

Consensus EPS · Q2 2026

$1.34

Consensus revenue · Q2 2026

$2.3B

Analysts

13

Expected report

Jul 28, 2026

Before open
Upcoming earnings
Locks in 22 hours · BMO: Locks 8:00 PM ET previous day
Revenue$2.3B$2.3B $2.4B
EPS$1.34$1.32 $1.36

What to watch

  • Analyst ratings: Mixed
Make your prediction

Analyst consensus

Based on estimates from 13 analysts.

  • Revenue$2.3B
  • EPS$1.34
  • EBITDA$616.1M
  • EBIT$409.1M
  • Net income$325.4M

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

  • Q1 2026+0.7%+3.2%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Xylem (XYL) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 2 analysts.

Low
$133.00
Consensus
$150.89
Median
$157.00
High
$161.00
Current
$119.75
Upside
+26.0%

Upside calculated vs most recent trading price of $119.75.

Analyst ratings

Consensus: Hold — based on 40 analyst ratings.

Buy 19Hold 20Sell 1

24-month trend

Recent analyst actions

  • Jul 20, 2026StifelBuy
  • Jul 16, 2026RBC CapitalOutperform
  • Jun 25, 2026JefferiesBuy
  • Apr 29, 2026UBSNeutral
  • Apr 29, 2026StifelBuy
  • Apr 29, 2026OppenheimerOutperform
  • Apr 29, 2026CitigroupBuy
  • Apr 29, 2026BarclaysOverweight
  • Apr 21, 2026UBSNeutral
  • Apr 16, 2026JP MorganOverweight

Frequently asked questions